Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) General Information

Description

Operator of a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive liver diseases. The company provides treatment for progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Acquirer
Advanz Pharma
Corporate Office
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada)‘s full profile, request access.

Request a free trial

Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada)‘s full profile, request access.

Request a free trial

Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) FAQs

  • Where is Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) headquartered?

    Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) is headquartered in Canada.

  • What industry is Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) in?

    Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada)’s primary industry is Drug Discovery.

  • Is Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) a private or public company?

    Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) is a Private company.

  • What is the current valuation of Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada)?

    The current valuation of Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) is .

  • What is Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada)’s current revenue?

    The current revenue for Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) is .

  • Who are Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada)’s investors?

    Intercept Pharmaceuticals has invested in Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada).

  • When was Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) acquired?

    Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) was acquired on 01-Jul-2022.

  • Who acquired Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada)?

    Intercept Pharmaceutical (Subsidiaries & Operations in Europe & Canada) was acquired by Advanz Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »